Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2227 | 4791 | 39.5 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
2227 | 2 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN | 4791 |
1652 | 1 | DOXORUBICIN//CARDIOTOXICITY//DEXRAZOXANE | 2553 |
4400 | 1 | CARDIOTOXICITY//ANTHRACYCLINES//CARDIO ONCOLOGY | 1792 |
24231 | 1 | CARDIOTOXICITY//INTERNAL MED PERIOPERAT ASSESSMENT//5 FLUOROURACIL | 319 |
33216 | 1 | BIMOLANE//PROBIMANE//MST 16 | 127 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CARDIOTOXICITY | authKW | 3124289 | 21% | 50% | 983 |
2 | ANTHRACYCLINES | authKW | 1012765 | 11% | 30% | 527 |
3 | DOXORUBICIN | authKW | 638828 | 17% | 13% | 791 |
4 | DEXRAZOXANE | authKW | 476332 | 2% | 69% | 108 |
5 | ADRIAMYCIN | authKW | 245728 | 5% | 17% | 222 |
6 | CARDIO ONCOLOGY | authKW | 158777 | 1% | 69% | 36 |
7 | ANTHRACYCLINE CARDIOTOXICITY | authKW | 153090 | 1% | 83% | 29 |
8 | ICRF 187 | authKW | 123049 | 1% | 74% | 26 |
9 | CARDIAC TOXICITY | authKW | 91463 | 1% | 22% | 65 |
10 | DOXORUBICIN CARDIOTOXICITY | authKW | 83253 | 0% | 93% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 13913 | 29% | 0% | 1385 |
2 | Cardiac & Cardiovascular System | 8457 | 17% | 0% | 834 |
3 | Pharmacology & Pharmacy | 5972 | 22% | 0% | 1071 |
4 | Toxicology | 2859 | 8% | 0% | 383 |
5 | Hematology | 1152 | 6% | 0% | 264 |
6 | Pediatrics | 438 | 4% | 0% | 207 |
7 | Medicine, Research & Experimental | 348 | 4% | 0% | 210 |
8 | Biophysics | 253 | 4% | 0% | 181 |
9 | Peripheral Vascular Diseases | 241 | 3% | 0% | 137 |
10 | Medicine, General & Internal | 222 | 5% | 0% | 236 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ROCKY MT CANC REHABIL | 68513 | 0% | 51% | 21 |
2 | UOC MAGNET ONANCE IMAGING | 32766 | 0% | 86% | 6 |
3 | PNEUMOL ONCOL ALERGOL | 25486 | 0% | 100% | 4 |
4 | TED ROGERS PROGRAM CARDIOTOX PREVENT | 25486 | 0% | 100% | 4 |
5 | CARDIONCOL UNIT | 22933 | 0% | 60% | 6 |
6 | UOC CARDIOL INTENS UNIT | 20387 | 0% | 80% | 4 |
7 | MED SCI MARIO A U | 20273 | 0% | 29% | 11 |
8 | CIR DRUG SCI | 19907 | 0% | 63% | 5 |
9 | MED BIOL UNIT | 16980 | 0% | 33% | 8 |
10 | UNIT 1451 | 14475 | 0% | 45% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOVASCULAR TOXICOLOGY | 28175 | 1% | 10% | 43 |
2 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 8188 | 2% | 1% | 98 |
3 | JOURNAL OF CLINICAL ONCOLOGY | 3545 | 2% | 1% | 97 |
4 | PEDIATRIC BLOOD & CANCER | 3440 | 1% | 1% | 50 |
5 | BIOCHEMICAL PHARMACOLOGY | 3022 | 2% | 1% | 96 |
6 | CANCER TREATMENT REPORTS | 2548 | 1% | 1% | 30 |
7 | RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY | 2452 | 1% | 1% | 30 |
8 | JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2368 | 1% | 1% | 50 |
9 | JOURNAL OF CARDIOVASCULAR MEDICINE | 2143 | 1% | 1% | 24 |
10 | PEDIATRIC HEMATOLOGY AND ONCOLOGY | 1916 | 1% | 1% | 25 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARDIOTOXICITY | 3124289 | 21% | 50% | 983 | Search CARDIOTOXICITY | Search CARDIOTOXICITY |
2 | ANTHRACYCLINES | 1012765 | 11% | 30% | 527 | Search ANTHRACYCLINES | Search ANTHRACYCLINES |
3 | DOXORUBICIN | 638828 | 17% | 13% | 791 | Search DOXORUBICIN | Search DOXORUBICIN |
4 | DEXRAZOXANE | 476332 | 2% | 69% | 108 | Search DEXRAZOXANE | Search DEXRAZOXANE |
5 | ADRIAMYCIN | 245728 | 5% | 17% | 222 | Search ADRIAMYCIN | Search ADRIAMYCIN |
6 | CARDIO ONCOLOGY | 158777 | 1% | 69% | 36 | Search CARDIO+ONCOLOGY | Search CARDIO+ONCOLOGY |
7 | ANTHRACYCLINE CARDIOTOXICITY | 153090 | 1% | 83% | 29 | Search ANTHRACYCLINE+CARDIOTOXICITY | Search ANTHRACYCLINE+CARDIOTOXICITY |
8 | ICRF 187 | 123049 | 1% | 74% | 26 | Search ICRF+187 | Search ICRF+187 |
9 | CARDIAC TOXICITY | 91463 | 1% | 22% | 65 | Search CARDIAC+TOXICITY | Search CARDIAC+TOXICITY |
10 | DOXORUBICIN CARDIOTOXICITY | 83253 | 0% | 93% | 14 | Search DOXORUBICIN+CARDIOTOXICITY | Search DOXORUBICIN+CARDIOTOXICITY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STERBA, M , POPELOVA, O , VAVROVA, A , JIRKOVSKY, E , KOVARIKOVA, P , GERSL, V , SIMUNEK, T , (2013) OXIDATIVE STRESS, REDOX SIGNALING, AND METAL CHELATION IN ANTHRACYCLINE CARDIOTOXICITY AND PHARMACOLOGICAL CARDIOPROTECTION.ANTIOXIDANTS & REDOX SIGNALING. VOL. 18. ISSUE 8. P. 899 -929 | 220 | 81% | 67 |
2 | CARVALHO, FS , BURGEIRO, A , GARCIA, R , MORENO, AJ , CARVALHO, RA , OLIVEIRA, PJ , (2014) DOXORUBICIN-INDUCED CARDIOTOXICITY: FROM BIOENERGETIC FAILURE AND CELL DEATH TO CARDIOMYOPATHY.MEDICINAL RESEARCH REVIEWS. VOL. 34. ISSUE 1. P. 106 -135 | 137 | 70% | 76 |
3 | CRIJNS, HJ , MOENS, AL , OCTAVIA, Y , TOCCHETTI, CG , GABRIELSON, KL , JANSSENS, S , (2012) DOXORUBICIN-INDUCED CARDIOMYOPATHY: FROM MOLECULAR MECHANISMS TO THERAPEUTIC STRATEGIES.JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. VOL. 52. ISSUE 6. P. 1213 -1225 | 113 | 76% | 225 |
4 | SIMUNEK, T , STERBA, M , POPELOVA, O , ADAMCOVA, M , HRDINA, R , GERSL, V , (2009) ANTHRACYCLINE-INDUCED CARDIOTOXICITY: OVERVIEW OF STUDIES EXAMINING THE ROLES OF OXIDATIVE STRESS AND FREE CELLULAR IRON.PHARMACOLOGICAL REPORTS. VOL. 61. ISSUE 1. P. 154 -171 | 116 | 84% | 262 |
5 | CHRISTENSON, ES , JAMES, T , AGRAWAL, V , PARK, BH , (2015) USE OF BIOMARKERS FOR THE ASSESSMENT OF CHEMOTHERAPY-INDUCED CARDIAC TOXICITY.CLINICAL BIOCHEMISTRY. VOL. 48. ISSUE 4-5. P. 223 -235 | 105 | 79% | 9 |
6 | ZAMORANO, JL , LANCELLOTTI, P , MUNOZ, D , ABOYANS, V , ASTEGGIANO, R , GALDERISI, M , HABIB, G , LENIHAN, DJ , LIP, GYH , LYON, AR , ET AL (2017) 2016 ESC POSITION PAPER ON CANCER TREATMENTS AND CARDIOVASCULAR TOXICITY DEVELOPED UNDER THE AUSPICES OF THE ESC COMMITTEE FOR PRACTICE GUIDELINES THE TASK FORCE FOR CANCER TREATMENTS AND CARDIOVASCULAR TOXICITY OF THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC).EUROPEAN JOURNAL OF HEART FAILURE. VOL. 19. ISSUE 1. P. 9 -42 | 122 | 44% | 1 |
7 | PLANA, JC , GALDERISI, M , BARAC, A , EWER, MS , KY, B , SCHERRER-CROSBIE, M , GANAME, J , SEBAG, IA , AGLER, DA , BADANO, LP , ET AL (2014) EXPERT CONSENSUS FOR MULTIMODALITY IMAGING EVALUATION OF ADULT PATIENTS DURING AND AFTER CANCER THERAPY: A REPORT FROM THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY AND THE EUROPEAN ASSOCIATION OF CARDIOVASCULAR IMAGING.JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY. VOL. 27. ISSUE 9. P. 911 -939 | 103 | 55% | 82 |
8 | TAN, TC , NEILAN, TG , FRANCIS, S , PLANA, JC , SCHERRER-CROSBIE, M , (2015) ANTHRACYCLINE-INDUCED CARDIOMYOPATHY IN ADULTS.COMPREHENSIVE PHYSIOLOGY. VOL. 5. ISSUE 3. P. 1517 -1540 | 123 | 66% | 3 |
9 | MONSUEZ, JJ , CHARNIOT, JC , VIGNAT, N , ARTIGOU, JY , (2010) CARDIAC SIDE-EFFECTS OF CANCER CHEMOTHERAPY.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 144. ISSUE 1. P. 3 -15 | 83 | 84% | 112 |
10 | CURIGLIANO, G , CARDINALE, D , DENT, S , CRISCITIELLO, C , ASEYEV, O , LENIHAN, D , CIPOLLA, CM , (2016) CARDIOTOXICITY OF ANTICANCER TREATMENTS: EPIDEMIOLOGY, DETECTION, AND MANAGEMENT.CA-A CANCER JOURNAL FOR CLINICIANS. VOL. 66. ISSUE 4. P. 310 -325 | 89 | 63% | 6 |
Classes with closest relation at Level 2 |